<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) OCTOBER 18, 1996
---------------
ECOGEN INC.
-----------
(Exact Name of Registrant as specified in its charter.)
DELAWARE 1-9579 22-247948
- -------- ------ ---------
(State or other (Commission File (IRS Employer
jurisdiction of Number) Identification No.)
incorporation)
2005 CABOT BOULEVARD WEST, LANGHORNE, PENNSYLVANIA 19047
---------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (215) 757-1590
---------------
Not Applicable
--------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE> 2
Item 5. Other Events
Ecogen Inc. recently announced that design problems with manufacturing
equipment developed specifically to produce a new formulation for its
biological pesticides will result in a shortage of product in the marketplace
during its fourth quarter of fiscal 1996, ending October 31.
Sales of CRYMAX(R), a bioinsecticide developed to control pests in vegetable,
tree, fruit and vine crops in California and Florida, and of Aspire(TM), a
biofungicide for postharvest rot control in citrus and pome fruits, will be
significantly lower than originally expected. Very limited quantities of
CRYMAX will be available for sale in the Company's fourth quarter which
represents the key months in the fall vegetable market in Florida and
California, resulting in lost product revenues for Ecogen. No Aspire will be
available for sale during the fourth quarter of fiscal 1996. The Company,
working with its distributors, has rescheduled the Aspire sales in the first
quarter of fiscal 1997. Due principally to these factors, overall product
sales and gross margins will be lower than the comparable fourth quarter of
fiscal 1995 and the Company will not meet its prior estimate of breakeven for
its 1996 fiscal year.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: October 18, 1996 ECOGEN INC.
BY:/s/ JAMES P. REILLY, JR.
--------------------------
Name: James P. Reilly, Jr.
Title: Chairman and
Chief Executive Officer
